Moreover, BMP9 was able to distinguish PoPH from liver disease without PAH in humans and rat models, suggesting a potential diagnostic application; and was predictive of transplant-free survival in all patients with group 1 PAH, therefore also implicating disease prognosis. Here, GDF2 is linked to Pulmonary arterial hypertension associated with portal hypertension.